+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Atomo Diagnostics Ltd (AT1) - Product Pipeline Analysis, 2024 Update

  • PDF Icon

    Company Profile

  • 39 Pages
  • December 2024
  • GlobalData
  • ID: 5740134
Atomo Diagnostics Ltd (Atomo) is a medical device company that designs, develops, manufactures and commercializes in-vitro diagnostic products. The company's products include HIV self-test products, HIV professional use test products and pregnancy test products among others. Its products are used for self-test consumer applications for detecting infectious diseases, measuring markers and hormone levels, and screening for chronic conditions. The company develops its products using the OEM device platform. It also offers custom devices. The company has operations in South Africa, the UK and Australia. Atomo is headquartered in Sydney, New South Wales, Australia.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Atomo Diagnostics Ltd
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.

Reasons to Buy:

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

  • Atomo Diagnostics Ltd Company Overview
  • Atomo Diagnostics Ltd Company Snapshot
  • Atomo Diagnostics Ltd Pipeline Products and Ongoing Clinical Trials Overview
  • Atomo Diagnostics Ltd - Pipeline Analysis Overview
  • Atomo Diagnostics Ltd - Key Facts
  • Atomo Diagnostics Ltd - Major Products and Services
  • Atomo Diagnostics Ltd Pipeline Products by Development Stage
  • Atomo Diagnostics Ltd Pipeline Products Overview
  • Atomo Blackburn Swab Device
  • Atomo Blackburn Swab Device Product Overview
  • Atomo Swab Based Rapid Test Device
  • Atomo Swab Based Rapid Test Device Product Overview
  • AtomoRapid - Allergy
  • AtomoRapid - Allergy Product Overview
  • AtomoRapid - Celiac Disease
  • AtomoRapid - Celiac Disease Product Overview
  • AtomoRapid - Chikungunya
  • AtomoRapid - Chikungunya Product Overview
  • AtomoRapid - Coagulation Monitoring
  • AtomoRapid - Coagulation Monitoring Product Overview
  • AtomoRapid - Dengue
  • AtomoRapid - Dengue Product Overview
  • AtomoRapid - Fleming
  • AtomoRapid - Fleming Product Overview
  • AtomoRapid - Hepatitis C
  • AtomoRapid - Hepatitis C Product Overview
  • AtomoRapid - Newton
  • AtomoRapid - Newton Product Overview
  • AtomoRapid COVID-19 (IgG/IgM) Test
  • AtomoRapid COVID-19 (IgG/IgM) Test Product Overview
  • AtomoRapid HIV
  • AtomoRapid HIV Product Overview
  • DaVinci Combo Self Test
  • DaVinci Combo Self Test Product Overview
  • Diagnostic Test - HCV
  • Diagnostic Test - HCV Product Overview
  • Rapid COVID-19 Self Test
  • Rapid COVID-19 Self Test Product Overview
  • Rapid Diagnostic Test - COVID-19
  • Rapid Diagnostic Test - COVID-19 Product Overview
  • Atomo Diagnostics Ltd - Key Competitors
  • Atomo Diagnostics Ltd - Key Employees
  • Atomo Diagnostics Ltd - Locations And Subsidiaries
  • Head Office
  • Recent Developments
  • Atomo Diagnostics Ltd, Recent Developments
  • Nov 13, 2024: Atomo Secures Australian Order for Supply of HIV Self-Tests
  • Jun 12, 2024: Procurement of Atomo HIV Self-Tests commencing through public health funding
  • Apr 15, 2024: Atomo secures significant order for HIV Self-Tests for LMIC Territories
  • Dec 09, 2023: Atomo and BBI enter into Collaboration Agreement
  • Jun 14, 2023: Atomo and Newfoundland Sign Agreement for HIV Testing in Europe
  • Feb 28, 2023: Significant purchase order for HIV self-tests for Europe
  • Jan 18, 2023: Atomo and NG Biotech sign new commercialisation agreement to expand the launch of a unique blood based rapid pregnancy test in key global markets
  • Feb 07, 2022: Owen Mumford announces partnerships with leading charities during HIV testing week
  • Jan 27, 2022: Atomo receives approval for its COVID-19 antigen test in NZ
  • Oct 26, 2021: Atomo HIV Self-Test - improved supply and advertising conditions in Australia
  • Appendix
  • Methodology
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Atomo Diagnostics Ltd Pipeline Products and Ongoing Clinical Trials Overview
  • Atomo Diagnostics Ltd Pipeline Products by Equipment Type
  • Atomo Diagnostics Ltd Pipeline Products by Indication
  • Atomo Diagnostics Ltd, Key Facts
  • Atomo Diagnostics Ltd, Major Products and Services
  • Atomo Diagnostics Ltd Number of Pipeline Products by Development Stage
  • Atomo Diagnostics Ltd Pipeline Products Summary by Development Stage
  • Atomo Blackburn Swab Device - Product Status
  • Atomo Blackburn Swab Device - Product Description
  • Atomo Swab Based Rapid Test Device - Product Status
  • Atomo Swab Based Rapid Test Device - Product Description
  • AtomoRapid - Allergy - Product Status
  • AtomoRapid - Allergy - Product Description
  • AtomoRapid - Celiac Disease - Product Status
  • AtomoRapid - Celiac Disease - Product Description
  • AtomoRapid - Chikungunya - Product Status
  • AtomoRapid - Chikungunya - Product Description
  • AtomoRapid - Coagulation Monitoring - Product Status
  • AtomoRapid - Coagulation Monitoring - Product Description
  • AtomoRapid - Dengue - Product Status
  • AtomoRapid - Dengue - Product Description
  • AtomoRapid - Fleming - Product Status
  • AtomoRapid - Fleming - Product Description
  • AtomoRapid - Hepatitis C - Product Status
  • AtomoRapid - Hepatitis C - Product Description
  • AtomoRapid - Newton - Product Status
  • AtomoRapid - Newton - Product Description
  • AtomoRapid COVID-19 (IgG/IgM) Test - Product Status
  • AtomoRapid COVID-19 (IgG/IgM) Test - Product Description
  • AtomoRapid HIV - Product Status
  • AtomoRapid HIV - Product Description
  • DaVinci Combo Self Test - Product Status
  • DaVinci Combo Self Test - Product Description
  • Diagnostic Test - HCV - Product Status
  • Diagnostic Test - HCV - Product Description
  • Rapid COVID-19 Self Test - Product Status
  • Rapid COVID-19 Self Test - Product Description
  • Rapid Diagnostic Test - COVID-19 - Product Status
  • Rapid Diagnostic Test - COVID-19 - Product Description
  • Atomo Diagnostics Ltd, Key Employees
  • Glossary
List of Figures
  • Atomo Diagnostics Ltd Pipeline Products by Equipment Type
  • Atomo Diagnostics Ltd Pipeline Products by Development Stage

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Resonance Health Ltd
  • Bluechiip Limited
  • Abbott Australia Pty., Ltd.
  • Cochlear Ltd
  • Abbott Diagnostics Division
  • Aged Care Diagnostics Pty Limited